Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2005 (Vol. 25, No. 12)

I-KODE.com-Home

URL:www.i-kode.com/web/I-KODE/index.cfm
  • Options to stop the flow of ads
  • Come-on headings
Here’s a site I include with a caution—read carefully through the site’s descriptions before signing up for anything. At first glance, I-KODE looks like an interesting idea. With a flashing headline that says FREE SERVICE and subheadlines that say Take Control of Your Scientific Mail and Clean Up Your Inbox, I-KODE would seem to be a tool for stopping junk mail and/or spam. While there does appear to be some ability to do this (at least for the SCIENTIFIC advertisers the site works with), I-KODE’s primary focus appears not to be as strongly aimed at this as much as ensuring that advertisers you want to hear from get their material to you. Yes, there are a few of these, I suppose, but I’m sure I speak for the vast majority of readers of this column when I say I’d rather spend an hour registering for a site that cut me off from ALL advertising spam than spend a minute registering for a site that points a few selected advertisers to me. Some may disagree with this opinion and to them I recommend I-KODE.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »